Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
|
1993 |
1994 |
1995 |
1996 |
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium |
|
1.4 |
4.2 |
6.1 |
5.5 |
6.4 |
3.4 |
|
|
|
|
|
Czech Republic |
|
|
|
41.2 |
43.2 |
48.8 |
56.8 |
52.8 |
46.0 |
47.8 |
55.0 |
55.6 |
Denmark |
|
|
|
|
|
|
|
11.0 |
7.0 |
|
10.3 |
12.7 |
Germany |
|
|
|
|
|
|
|
|
10.2 |
11.4 |
10.0 |
10.2 |
Greece |
|
|
0.0 |
0.2 |
0.0 |
0.3 |
0.0 |
0.2 |
0.3 |
0.4 |
0.7 |
0.6 |
Spain |
|
|
|
|
1.1 |
1.1 |
2.3 |
2.1 |
2.7 |
3.0 |
3.7 |
|
France |
|
|
|
|
|
1.8 |
|
1.6 |
|
|
|
2.1 |
Ireland |
|
4.9 |
3.3 |
8.0 |
6.3 |
7.0 |
4.8 |
5.7 |
6.5 |
9.9 |
8.6 |
|
Italy |
(1) |
0.2 |
0.3 |
0.3 |
0.4 |
0.6 |
0.9 |
1.1 |
1.0 |
1.0 |
1.0 |
1.0 |
Cyprus |
|
|
|
|
|
|
|
|
|
6.1 |
6.0 |
6.2 |
Latvia |
|
|
|
|
|
|
|
|
|
|
11.3 |
15.1 |
Lithuania |
|
|
|
|
|
|
|
|
|
|
3.0 |
4.8 |
Luxembourg |
(2) |
|
|
0.0 |
4.0 |
2.0 |
3.0 |
2.0 |
1.0 |
1.0 |
0.0 |
0.0 |
Hungary |
(3) |
|
|
|
7.1 |
12.2 |
14.0 |
10.7 |
7.5 |
7.0 |
6.3 |
8.2 |
Malta |
(4) |
|
|
|
0.8 |
0.4 |
|
|
|
|
|
1.2 |
Netherlands |
|
|
3.5 |
7.2 |
10.3 |
9.5 |
8.1 |
6.7 |
4.8 |
4.1 |
5.6 |
7.0 |
Austria |
(5) |
|
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Poland |
(6) |
|
|
|
|
3.8 |
6.0 |
6.7 |
5.8 |
6.0 |
8.1 |
|
Portugal |
|
|
|
|
|
|
|
0.0 |
0.0 |
|
|
0.8 |
Slovenia |
|
|
|
|
|
0.2 |
|
0.7 |
|
|
1.0 |
1.0 |
Slovakia |
|
|
1.7 |
1.2 |
2.0 |
2.6 |
3.2 |
2.3 |
6.8 |
7.8 |
15.1 |
25.4 |
Finland |
|
|
|
|
|
|
41.1 |
41.9 |
30.8 |
30.0 |
33.9 |
33.9 |
Sweden |
|
|
|
|
|
|
|
|
28.7 |
32.3 |
34.2 |
32.1 |
United Kingdom |
(7) |
11.0 |
9.0 |
10.0 |
9.0 |
9.0 |
9.0 |
8.0 |
4.0 |
3.0 |
3.0 |
3.0 |
Bulgaria |
|
|
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.2 |
0.9 |
Romania |
|
|
|
|
|
|
|
|
|
0.3 |
0.5 |
1.0 |
Notes: (1) Data refer to all treatments. (2) Data refer to all treatments. (3) Data refer to all treatments. (4) In order to include time trends, data reported in Table TDI-3 refer to 1 outpatient centre for which data were available for all the time period. (5) Data only refer to clients in substitution treatment, using opiates as primary drug. (6) Data refer to all treatments. Stimulants only refer to amphetamines. (7) Data refer to all treatments. Stimulants only refer to amphetamines. Source: 2004 Reitox national reports - standard table 4 - first treatments | ||||||||||||